Individualized medication of voriconazole: a practice guideline of the division of therapeutic drug monitoring, chinese pharmacological society
Ther. Drug Monit; 40 (60), 2018
BACKGROUND:
Voriconazole (VRZ) is a second-generation triazole antifungal agent with broad-spectrum activity. It is available in both intravenous and oral formulations, and is primarily indicated for treating invasive aspergillosis. The most commonly used dose for adults is 4 mg/kg or 200 mg twice daily....